Resultado de búsqueda
Hace 3 días · Ship To Shore. ★★★★. NEW WEST. Spidering his way into the bleakest corner of his first album in six years, Richard Thompson sees through the eyes of a soldier struggling with PTSD on the quietly crushing The Fear Never Leaves You. “Numb is heaven, oblivion wealth,” sings the 75-year-old master of the dark arts in his customary ...
Hace 4 días · Keji Zhao received his undergraduate degree from Changwei Normal College in Weifang, China in 1980, his M.S. degree from Northeast Normal University in Changchun, China in 1985, and his Ph.D. from the University of Geneva, Switzerland in 1996. He was a Damon Runyon-Walter Winchel Cancer Research postdoctoral fellow at Stanford University in the ...
Hace 3 días · It’s proof that at the age of 75 Thompson can still startle. Elsewhere he’s scuzziness itself on Old Pack Mule, while Maybe climaxes with a fearsome guitar squall midway between Jerry Garcia and John Frusciante, and Life’s A Bloody Show is quietly incandescent. He’s peaking again. Richard Thompson: Ship To Shore: Price Comparison.
21 de may. de 2024 · Bethesda, MD 20892-1360. 240-858-3366. chuan.wu@nih.gov. Research Topics. 1. Immune-neuron crosstalk regulates gut sensation. The intestinal epithelium represents the largest interface which protects the body from potential danger while sensing external milieu.
Hace 4 días · Bldg. 10 CRC Room 3-5322 (office), Room 3-5288 (lab) 10 Center Drive Bethesda, MD 20892 United States. 301-402-4846. elinoffj@mail.nih.gov
Hace 3 días · Richard Thompson kickstarted his career as co-founder, lead guitarist and songwriter of Fairport Convention – a trailblazing rock outfit that ignited the British Folk Rock movement in the late 1960s. Now a wildly successful soloist – with 19 solo albums and a string of awards under his belt – Thompson received perhaps the highest praise ...
20 de may. de 2024 · Bethesda, MD 20892. 240-760-6223. james_yang@nih.gov. Research Topics. Immune Rejection Mechanisms in Melanoma, Renal Cancer and Other Human Cancers. Our laboratory's major interest is in understanding the mechanisms of immune tumor rejection and then developing reagents to translate this understanding into clinical trials.
